EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:64360 - tocilizumab
| ChEBI ID | CHEBI:64360 |
| ChEBI Name | tocilizumab |
| Stars | |
| Definition | binds specifically to both soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R), and has been shown to inhibit IL-6-mediated signaling through these receptor |
| Last Modified | 11 April 2012 |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tocilizumab (CHEBI:64360) has role anti-HIV agent (CHEBI:64946) |
| tocilizumab (CHEBI:64360) has role anti-inflammatory agent (CHEBI:67079) |
| tocilizumab (CHEBI:64360) has role anticonvulsant (CHEBI:35623) |
| tocilizumab (CHEBI:64360) has role anticoronaviral agent (CHEBI:149553) |
| tocilizumab (CHEBI:64360) has role antidepressant (CHEBI:35469) |
| tocilizumab (CHEBI:64360) has role antihypertensive agent (CHEBI:35674) |
| tocilizumab (CHEBI:64360) has role antimicrobial agent (CHEBI:33281) |
| tocilizumab (CHEBI:64360) has role antineoplastic agent (CHEBI:35610) |
| tocilizumab (CHEBI:64360) has role antipsychotic agent (CHEBI:35476) |
| tocilizumab (CHEBI:64360) has role antirheumatic drug (CHEBI:35842) |
| tocilizumab (CHEBI:64360) has role antiviral agent (CHEBI:22587) |
| tocilizumab (CHEBI:64360) has role cardiovascular drug (CHEBI:35554) |
| tocilizumab (CHEBI:64360) has role hypoglycemic agent (CHEBI:35526) |
| tocilizumab (CHEBI:64360) has role immunosuppressive agent (CHEBI:35705) |
| tocilizumab (CHEBI:64360) has role ophthalmology drug (CHEBI:66981) |
| tocilizumab (CHEBI:64360) is a organic molecular entity (CHEBI:50860) |
| tocilizumab (CHEBI:64360) is a unclassifieds (CHEBI:27189) |
| Synonyms | Source |
|---|---|
| Actemra | ChEMBL |
| ATLIZUMAB | ChEMBL |
| BAT-1806 | ChEMBL |
| BAT1806 | ChEMBL |
| Biib800 | ChEMBL |
| BIIB-800 | ChEMBL |
| Brand Names | Source |
|---|---|
| Actemra roactemra | ChEMBL |
| Roactemra | ChEMBL |